A novel single-nucleotide polymorphism at the 5?-flanking region ofSAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis
Open Access
- 6 June 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (6) , 1266-1272
- https://doi.org/10.1002/1529-0131(200106)44:6<1266::aid-art218>3.0.co;2-3
Abstract
Objective To address whether the γ haplotype at exon 3 of the SAA1 gene is directly associated with type AA amyloidosis or is merely in linkage with an unknown polymorphism that is primarily associated with disease risk, we examined the SAA1 gene for new polymorphisms. Methods We analyzed DNA samples from 44 rheumatoid arthritis (RA) patients with AA amyloidosis (amyloid group), 55 RA patients without AA amyloidosis (RA group), and 58 non‐RA healthy subjects (non‐RA group). We also examined DNA samples from 50 Caucasians to compare linkage disequilibrium relationships involving SAA1 region polymorphisms between Japanese and Caucasoid populations. Results We observed 3 novel single‐nucleotide polymorphisms (SNPs) in the 5′‐flanking region of SAA1: −61C/G, −13T/C, and −2G/A. Comparison of allele frequencies and ratios of individuals with particular alleles between the study groups revealed statistically significant differences between the amyloid and RA groups and between the amyloid and non‐RA groups. Statistical analysis revealed that the −13T/C SNP was strongly associated with AA amyloidosis. In addition, we found tight linkage between the −13T allele and the α haplotype, rather than the β haplotype, at exon 3 in the Caucasoid population, while −13T was closely linked to the γ and β haplotypes, rather than the α haplotype, in the Japanese population. Since the linkage disequilibrium relationship was reversed between the Japanese and Caucasoid populations, different exon 3 haplotypes of SAA1 are found to be associated with the risk of AA amyloidosis in different ethnic groups. Conclusion Our data suggest that the SAA1 −13T allele, rather than SAA1 exon 3 haplotypes, is primarily associated with AA amyloidosis risk.Keywords
This publication has 16 references indexed in Scilit:
- The Kinetics and Magnitude of the Synergistic Activation of the Serum Amyloid A Promoter by IL‐1β and IL‐6 is Determined by the Order of Cytokine AdditionScandinavian Journal of Immunology, 1999
- Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1β and TNF-α compared to IL-6Journal of Immunological Methods, 1997
- SECONDARY AMYLOIDOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DIAGNOSTIC AND PROGNOSTIC VALUE OF GASTRODUODENAL BIOPSYRheumatology, 1996
- A novel allelic variant of serum amyloic A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA– amyloidosisHuman Molecular Genetics, 1995
- Organization of the Region Encompassing the Human Serum Amyloid A (SAA) Gene Family on Chromosome 11p15.1Genomics, 1994
- Localization of Four Human Serum Amyloid A (SAA) Protein Superfamily Genes to Chromosome 11p: Characterization of a Fifth SAA-Related Gene SequenceGenomics, 1993
- A Novel Polymorphism of Human Serum Amyloid A Protein, SAA1γ, Is Characterized by Alanines at Both Residues 52 and 57Archives of Biochemistry and Biophysics, 1993
- Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P ComponentNew England Journal of Medicine, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNABiochemistry, 1985